Guiqi Zhu

Medicine · Health Sciences

9h-index565citations19works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(5), Hepatocellular Carcinoma Treatment and Prognosis(4), Lung Cancer Treatments and Mutations(3), Cancer Genomics and Diagnostics(3), Ferroptosis and cancer prognosis(3)

Publications19 total

Correction to “Laser-Induced Combinatorial Chemotherapeutic, Chemodynamic, and Photothermal Therapy for Hepatocellular Carcinoma Based on Oxaliplatin-Loaded Metal–Organic Frameworks”
ACS Applied Materials & Interfaces·2025Open Access
CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor
Cell Discovery·2023· 283 citedOpen Access
Laser-Induced Combinatorial Chemotherapeutic, Chemodynamic, and Photothermal Therapy for Hepatocellular Carcinoma Based on Oxaliplatin-Loaded Metal–Organic Frameworks
ACS Applied Materials & Interfaces·2023· 28 citedOpen Access
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world study
BJS Open·2022· 55 citedOpen Access
Comprehensive analysis of complement-associated molecular features in hepatocellular carcinoma
Acta Biochimica et Biophysica Sinica·2022· 2 citedOpen Access
Selection of lncRNAs That Influence the Prognosis of Osteosarcoma Based on Copy Number Variation Data
Journal of Oncology·2022· 9 citedOpen Access
Risk stratification of LI-RADS M and LI-RADS 4/5 combined hepatocellular cholangiocarcinoma: prognostic values of MR imaging features and clinicopathological factors
European Radiology·2022· 10 cited
Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma
Cellular and Molecular Gastroenterology and Hepatology·2022· 48 citedOpen Access
CD36 <sup>+</sup> Cancer-Associated Fibroblasts Provide Immunosuppressive Microenvironment for Hepatocellular Carcinoma via Secretion of Macrophage Migration Inhibitory Factor
SSRN Electronic Journal·2022Open Access
Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study
Molecular Oncology·2021· 39 citedOpen Access
Author response for "Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study"
2021
Identification and validation of a new gene signature predicting prognosis of hepatocellular carcinoma patients by network analysis of stemness indices
Expert Review of Gastroenterology & Hepatology·2020· 12 cited
<p>A PI-RADS-Based New Nomogram for Predicting Clinically Significant Prostate Cancer: A Cohort Study</p>
Cancer Management and Research·2020· 4 citedOpen Access
S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial
Expert Review of Pharmacoeconomics & Outcomes Research·2019· 6 cited
Cost‐effectiveness analysis of cabozantinib as second‐line therapy in advanced hepatocellular carcinoma
Liver International·2019· 48 citedOpen Access
S-1 or gemcitabine adjuvant therapy in resected pancreatic cancer: a cost-effectiveness analysis based on the JASPAC-01 trial
Figshare·2019Open Access
Aspartate aminotransferase-to-platelet ratio index predicts prognosis of hepatocellular carcinoma after postoperative adjuvant transarterial chemoembolization
Cancer Management and Research·2018· 16 citedOpen Access
[Differential expressions analysis of piwi-interacting RNAs in hepatocellular carcinoma].
PubMed·2018· 5 cited
Development and Validation of a New Tumor-Based Gene Signature Predicting Prognosis of HBV-Included Resected Hepatocellular Carcinoma Patients
SSRN Electronic Journal·2018Open Access

Frequent Co-authors

Jia Fan(10), Ying‐Hong Shi(10), Zheng Tang(8), Wei‐Feng Qu(8), Chenyang Tao(8), Run Huang(7), Jian Zhou(6), Yuan Fang(5), Jun Gao(5), Zhen‐Bin Ding(5), Jian Zhou(5), Xi‐Fei Jiang(5), Haixiang Sun(4), Shushu Song(4), Wei‐Ren Liu(4), Xiutao Fu(4), Zhi Dai(4), Weiren Liu(4), Xiaoling Wu(3), Zhi Dai(3)